Table 3.
Patient Number | Localisation | Expression of HOXA10 |
---|---|---|
C1 | Clivus | − |
C2 | Clivus | − |
C3 | Clivus | + |
C4 | Clivus | + |
C5 | Clivus | + |
S1 | Sacrum | ++ |
S2 | Sacrum | ++ |
S3 | Sacrum | +++ |
S4 | Sacrum | +++ |
S5 | Sacrum | +++ |
S6 | Sacrum | +++ |
S7 | Sacrum | +++ |
S8 | Sacrum | +++ |
S9 | Sacrum | ++ |
S10 | Sacrum | ++ |
S11 | Sacrum | +++ |
S12 | Sacrum | +++ |
S13 | Sacrum | +++ |
S14 | Sacrum | +++ |
S15 | Sacrum | +++ |
S16 | Sacrum | +++ |
S17 | Sacrum | +++ |
S18 | Sacrum | +++ |
S19 | Sacrum | +++ |
S20 | Sacrum | +++ |
S21 | Sacrum | +++ |
S22 | Sacrum | +++ |
S23 | Sacrum | +++ |
S24 | Sacrum | +++ |
Clivus chordomas (n = 5) have a weaker expression of HOXA10 than sacrum chordomas (n = 24) shown by immunohistochemistry.